Sign in

CIK 0001130166

  • Non-accelerated filer
  • Smaller reporting company

Bio Green Med Solution, Inc.

Sign in to watch
Tickers
BGMS BGMSP
Exchange
Nasdaq, OTC
Industry
Wholesale-Durable Goods, NEC
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
911766850
Phone
+1 908-517-7330
Business address
200 CONNELL DRIVE, SUITE 1500, BERKELEY HEIGHTS, NJ, 07922
Former names
Cyclacel Pharmaceuticals, Inc., XCYTE THERAPIES INC

Securities

  • BGMS Common Stock Nasdaq
  • BGMSP Common stock OTC
  1. 4 Open-market buy 10% owner bought 23,900 shares at $2.09 ($49,951)
  2. 4 Open-market buy E.V.P., Finance & C.O.O. bought 1,950 shares at $2.25 ($4,388)
  3. 4 Open-market buy President & C.E.O. bought 12,500 shares at an average $2.32 ($28,990)
  4. 4 Open-market buy President & C.E.O. bought 15,000 shares at an average $2.59 ($38,780)
  5. 4 Open-market sale 10% owner sold 1,600 shares at $2.84 ($4,544)
  6. 4 Open-market sale 10% owner sold 66,700 shares at an average $2.94 ($195,978)
  7. 4/A Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale 10% owner sold 38,900 shares at $3.09 ($120,201)
  10. 4 Open-market buy President & C.E.O. bought 5,800 shares at $2.75 ($15,950)
  11. 4 Open-market buy Senior VP, Research bought 3,000 shares at $2.90 ($8,700)
  12. 4 Open-market buy VP, Business Development bought 5,000 shares at an average $2.89 ($14,444)
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale 10% owner sold 195,700 shares at an average $4.07 ($797,259)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 15 of 26 · 511 filings